Long-term outcomes and treatment patterns in Waldenström macroglobulinemia patients who discontinue Bruton tyrosine kinase inhibitor (BTKi) therapy
瓦尔登斯特伦巨球蛋白血症患者停用布鲁顿酪氨酸激酶抑制剂(BTKi)治疗后的长期预后和治疗模式
期刊:Blood Cancer Journal
影响因子:11.6
doi:10.1038/s41408-025-01415-5
Chohan, Karan L; Gensini, Lorenzo; Seif, Sherif; Sun, Xiaowen; Feng, Lei; Becnel, Melody R; Gaballa, Mahmoud M; Lee, Hans C; Pasvolsky, Oren; Patel, Krina K; Ye, J Christine; Weber, Donna M; Orlowski, Robert Z; Thomas, Sheeba K